Biofrontera AG ADR sell nvestor
Start price
16.04.22
/
50%
€2.14
Target price
16.04.23
€1.00
Performance (%)
-28.04%
End price
30.04.22
€1.54
Summary
This prediction ended on 30.04.22 with a price of €1.54. The prediction for Biofrontera AG ADR closed with a convincing performance of -28.04%. nvestor has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biofrontera AG ADR | - | - | - |
| iShares Core DAX® | -0.922% | -1.078% | 12.165% |
| iShares Nasdaq 100 | 0.371% | -0.556% | 38.622% |
| iShares Nikkei 225® | 2.224% | -2.825% | 19.015% |
| iShares S&P 500 | -0.026% | -0.788% | 28.485% |
According to nvestor what are the pros and cons of Biofrontera AG ADR for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
High valuation
negative Cash Flow expected
Increased challenges to pay loans and raise capital
Bad culture
Little innovation
Few uniques
Dependend from some customers or products
Higher risks for its business
Significant cyclical dependencies
Business model of the past or high risk
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Low dividend yield expected
Bad rating
Little Investments for future growth
Risky balance sheet
ROE lower than 10% per year
Below average Management
Growths slower than the competition
Sustainability is little important
high free float
Below average Marketposition
Little known brand
Comments by nvestor for this prediction
In the thread Biofrontera AG diskutieren
In the thread Trading Biofrontera AG
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.
Stopped prediction by nvestor for Biofrontera AG ADR
Biofrontera AG ADR
Start price
Target price
Perf. (%)
€5.60
12.09.20
12.09.20
€4.00
19.09.20
19.09.20
0.00%
19.09.20
19.09.20
Probably not worthwhile Investment
High valuation
negative Cash Flow expected
Increased challenges to pay loans and raise capital
